Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy
Clinical trial NCT05781308 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05781308
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2025-06-02
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.